“I feel like [HIFU] provided patients this intermediary treatment option…It was less invasive than radiation and surgery, but still provided cancer control, or at least for some patients delayed the time until they needed a more radical treatment,” says Jennifer A. Linehan, MD.
In this video, Jennifer A. Linehan, MD, discusses her clinical practice and experience with high-intensity focused ultrasound (HIFU) for patients with prostate cancer. Linehan is an associate professor of urology and urologic oncology at Saint John’s Cancer Institute in Santa Monica, California.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.